Cargando…

Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a common malignancy worldwide with a high mortality rate. lncRNA SFTA1P is highly expressed in HCC. We aimed to study the role of SFTA1P in HCC and its relationship with miR-4766-5p. MATERIALS AND METHODS: The levels of SFTA1P in HCC tissues and cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Guohong, Yang, Yimei, Lv, Mengxin, Huang, Tian, Zhan, Xiaoyan, Kang, Wei, Hou, Jianghou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533222/ https://www.ncbi.nlm.nih.gov/pubmed/33061455 http://dx.doi.org/10.2147/OTT.S248660

Ejemplares similares

miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3
por: Huang, Guohong, et al.
Publicado: (2021)

LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation
por: Luo, Aoran, et al.
Publicado: (2022)

LncRNA SFTA1P mediates positive feedback regulation of the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer
por: Zhu, Bowen, et al.
Publicado: (2021)

MiR-4766-5p Inhibits The Development And Progression Of Gastric Cancer By Targeting NKAP
por: Wei, Yaning, et al.
Publicado: (2019)

lncRNA OGFRP1 promotes tumor progression by activating the AKT/mTOR pathway in human gastric cancer
por: Zhang, Jingzhou, et al.
Publicado: (2021)

LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways
por: Liu, Zhihui, et al.
Publicado: (2020)

Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway
por: Meng, Qian, et al.
Publicado: (2020)

Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
por: Chen, Wei, et al.
Publicado: (2018)

LncRNA MEG3 inhibits rheumatoid arthritis through miR‐141 and inactivation of AKT/mTOR signalling pathway
por: Li, Guoqing, et al.
Publicado: (2019)

LncRNA NORAD Promotes Proliferation And Inhibits Apoptosis Of Gastric Cancer By Regulating miR-214/Akt/mTOR Axis
por: Tao, Wei, et al.
Publicado: (2019)

Knockdown of lncRNA TDRG1 Inhibits Tumorigenesis in Endometrial Carcinoma Through the PI3K/AKT/mTOR Pathway
por: Sun, Ruimei, et al.
Publicado: (2019)

C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers
por: Paszkowska, Anna, et al.
Publicado: (2022)

The lncRNA H19/miR-766-3p/S1PR3 Axis Contributes to the Hyperproliferation of Keratinocytes and Skin Inflammation in Psoriasis via the AKT/mTOR Pathway
por: He, Yuexi, et al.
Publicado: (2021)

LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis
por: Yao, Xinliang, et al.
Publicado: (2018)

LncRNA‐LOC101928316 contributes to gastric cancer progression through regulating PI3K‐Akt‐mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2019)

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis
por: Cai, Haiping, et al.
Publicado: (2020)

LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy
por: Chen, Ke, et al.
Publicado: (2021)

LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway
por: Qi, Fei, et al.
Publicado: (2023)

Coordination of the AMPK, Akt, mTOR, and p53 Pathways under Glucose Starvation
por: Zhou, Yifan, et al.
Publicado: (2022)

The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway
por: Wan, Yunyan, et al.
Publicado: (2020)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit Atherosclerosis
por: You, Ganhua, et al.
Publicado: (2020)

Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017)

Examining the role of the surfactant family member SFTA3 in interneuron specification
por: Chen, Christopher Y., et al.
Publicado: (2018)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

S1P(1) receptor overrides regulatory T cell-mediated immune suppression through Akt-mTOR
por: Liu, Guangwei, et al.
Publicado: (2009)

Circular RNA hsa_circ_0000277 sequesters miR-4766-5p to upregulate LAMA1 and promote esophageal carcinoma progression
por: Zhou, Peng Li, et al.
Publicado: (2021)

Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer
por: Lu, Junmi, et al.
Publicado: (2020)

LncRNA‐HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR‐664b‐3p/Rheb/mTOR pathway
por: Yu, Xuecheng, et al.
Publicado: (2023)

Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway
por: Li, Zhixiang, et al.
Publicado: (2019)

LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K/AKT/mTOR axis
por: Wang, Sixuan, et al.
Publicado: (2022)

The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer
por: Ma, Hongwei, et al.
Publicado: (2018)

PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling
por: Li, Qing, et al.
Publicado: (2023)

The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
por: Dai, Tianyu, et al.
Publicado: (2021)

miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR
por: Li, Wenhua, et al.
Publicado: (2015)

Decision-making by p53 and mTOR
por: Maki, Carl G.
Publicado: (2010)

AKT shuts down the TOR network
por: Short, Ben
Publicado: (2013)

lncRNA TINCR facilities bladder cancer progression via regulating miR-7 and mTOR
por: Xu, Guoying, et al.
Publicado: (2020)

LncRNA TMPO‐AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR‐329‐3p to stimulate FOXK1‐mediated AKT/mTOR signaling pathway
por: Guo, Xiaobo, et al.
Publicado: (2020)

LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
por: Song, Xue-zhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_84dg6ojrstbluvkmo0jn7fnfd0